![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Multi-drug Resistant Tuberculosis in Travellers
Tuberculosis remains a major global public health crisis, and multidrug-resistant tuberculosis (MDR-TB) has become a threat to disease control in many countries. More than 20% of humanity is latently infected ...
-
Article
Open AccessQuality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review
Despite more than 60 years of clinical trials, tuberculosis (TB) still causes a high global burden of mortality and morbidity. Treatment currently requires multiple drugs in combination, taken over a prolonged...
-
Article
Open AccessQuality of outcome reporting in phase II studies in pulmonary tuberculosis
Tuberculosis (TB) remains a major killer amongst the infectious diseases. Current treatment involves a four-drug regimen for at least 6 months. New drugs and regimens are required to shorten treatment duration...